Intrinsic Medicine, which develops treatments for gut-related conditions using synthetic biology-manufactured human identical milk oligosaccharide (HiMO) molecules, has cancelled plans to go public in the US. Learn more about the withdrawn IPO, and find out about similar companies in which you can invest.
On July 25, 2022, Intrinsic Medicine announced it was cancelling its plans to go public. Originally, it had planned to conduct an IPO on the Nasdaq under the ticker symbol “INRX.” Altogether, the company had planned to raise around $25 million by offering 4.2 million stocks at a price of $5.00 – $7.00.
Spartan Capital Securities, LLC was slated to act as the lead underwriter of the deal. You can read more about the IPO in this prospectus submitted to the US Securities and Exchange Commission (SEC) on May 4, 2022.
Current market conditions have been cited as the reason for for the cancellation. A future IPO date has not been announced.
Even though you won’t be able to buy Intrinsic Medicine stock, you can still invest in other biotechnology companies that develop treatments for gut-related conditions.
| Company | Stock info |
|---|---|
| Finch Therapeutics Group | NasdaqGS: FNCH |
| Seres Therapeutics | NasdaqGS: MCRB |
| Evelo Biosciences | NasdaqGS: EVLO |
| PureTech Health | NasdaqGM: PRTC |
You’ll need a brokerage account to buy and sell stocks. Here’s how it works:
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Here are the 10 best gold stocks based on year-to-date returns for April 2024.
Read more…
Here’s what happens to your securities if your brokerage fails, and how your assets are protected by SIPC and FDIC.
Read more…
Treasury Bills are fixed-income assets with maturities of less than one year. Here’s what to know before investing.
Read more…A look at GSD Capital’s highlights, limitations, fees and investment strategies.
Explore the best bonuses for opening a new brokerage account.
These are the best trading platforms for beginners, according to Finder’s comprehensive analysis.
We rate robo-advisors across eight key categories, including ongoing costs, minimum deposit requirements, portfolio mix and more.
A beginner-friendly investing platform with fractional shares and no commissions on stocks and ETFs.
Features and fees to consider before you open an account with this trading platform.
SoFi is a commission-free platform with both active and automated investment accounts.
What you need to know about investing in the leading indicator for the overall US stock market.
Take advantage of $0 trades and no investment minimums with this well-known broker.
A deep dive into the highlights and limitations of Robinhood.